Caspases: pharmacological manipulation of cell death.

Caspases, a family of cysteine proteases, play a central role in apoptosis. During the last decade, major progress has been made to further understand caspase structure and function, providing a unique basis for drug design. This Review gives an overview of caspases and their classification, structure, and substrate specificity. We also describe the current knowledge of how interference with caspase signaling can be used to pharmacologically manipulate cell death.

[1]  D. Green,et al.  A unified model for apical caspase activation. , 2003, Molecular cell.

[2]  S. Korsmeyer,et al.  Cell Death Critical Control Points , 2004, Cell.

[3]  M. Peter,et al.  Two CD95 (APO‐1/Fas) signaling pathways , 1998, The EMBO journal.

[4]  V. Dixit,et al.  Death receptors: signaling and modulation. , 1998, Science.

[5]  J. Kofron,et al.  Distinctive Roles of PHAP Proteins and Prothymosin-α in a Death Regulatory Pathway , 2003, Science.

[6]  Ingo Schmitz,et al.  The Role of c-FLIP in Modulation of CD95-induced Apoptosis* , 1999, The Journal of Biological Chemistry.

[7]  A. Chinnaiyan.  The apoptosome: heart and soul of the cell death machine. , 1999, Neoplasia.

[8]  D. B. Yehuda,et al.  Two splicing variants of a new inhibitor of apoptosis gene with different biological properties and tissue distribution pattern , 2001, FEBS letters.

[9]  C. Weber,et al.  The death domain superfamily: a tale of two interfaces? , 2001, Trends in biochemical sciences.

[10]  F. Martinon,et al.  Inflammatory Caspases Linking an Intracellular Innate Immune System to Autoinflammatory Diseases , 2004, Cell.

[11]  C. Wiessner,et al.  Protective effect of a caspase inhibitor in models for cerebral ischemia in vitro and in vivo. , 2000, Cellular and molecular biology.

[12]  Young Chul Park,et al.  Structural Basis of Caspase Inhibition by XIAP Differential Roles of the Linker versus the BIR Domain , 2001, Cell.

[13]  N. Hoglen,et al.  Characterization of IDN-6556 (3-{2-(2-tert-Butyl-phenylaminooxalyl)-amino]-propionylamino}-4-oxo-5-(2,3,5,6-tetrafluoro-phenoxy)-pentanoic Acid): a Liver-Targeted Caspase Inhibitor , 2004, Journal of Pharmacology and Experimental Therapeutics.

[14]  John Calvin Reed,et al.  Peptides Targeting Caspase Inhibitors* , 2003, The Journal of Biological Chemistry.

[15]  J C Reed,et al.  IAP family proteins--suppressors of apoptosis. , 1999, Genes & development.

[16]  R. Liddington,et al.  Dimer formation drives the activation of the cell death protease caspase 9 , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[17]  P. Vandenabeele,et al.  A Novel Caspase-2 Complex Containing TRAF2 and RIP1* , 2005, Journal of Biological Chemistry.

[18]  G. Salvesen,et al.  ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas , 2000, Current Biology.

[19]  M. Moskowitz,et al.  Attenuation of Delayed Neuronal Death after Mild Focal Ischemia in Mice by Inhibition of the Caspase Family , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[20]  John Calvin Reed,et al.  Apoptosis-based therapies , 2002, Nature Reviews Drug Discovery.

[21]  M. Peter,et al.  Analysis of the CD95 (APO-1/Fas) death-inducing signaling complex by high-resolution two-dimensional gel electrophoresis. , 2000, Methods in enzymology.

[22]  A. Grosse-Wilde,et al.  Caspase‐10 is recruited to and activated at the native TRAIL and CD95 death‐inducing signalling complexes in a FADD‐dependent manner but can not functionally substitute caspase‐8 , 2002, The EMBO journal.

[23]  S. Fesik,et al.  Insights into Programmed Cell Death through Structural Biology , 2000, Cell.

[24]  L. Tartaglia,et al.  A novel domain within the 55 kd TNF receptor signals cell death , 1993, Cell.

[25]  L K Miller,et al.  An exegesis of IAPs: salvation and surprises from BIR motifs. , 1999, Trends in cell biology.

[26]  P. Krammer.  The CD95(APO-1/Fas)/CD95L system. , 1998, Toxicology letters.

[27]  Mark A. Murcko,et al.  Structure and mechanism of interleukin-lβ converting enzyme , 1994, Nature.

[28]  Y. Lazebnik,et al.  Caspases: enemies within. , 1998, Science.

[29]  Ingo Schmitz,et al.  Differential Modulation of Apoptosis Sensitivity in CD95 Type I and Type II Cells* , 1999, The Journal of Biological Chemistry.

[30]  K. Hofmann,et al.  The modular nature of apoptotic signaling proteins , 1999, Cellular and Molecular Life Sciences CMLS.

[31]  D. Vaux,et al.  Diablo Promotes Apoptosis by Removing Miha/Xiap from Processed Caspase 9 , 2001, The Journal of cell biology.

[32]  Xiaodong Wang,et al.  Cytochrome c Promotes Caspase-9 Activation by Inducing Nucleotide Binding to Apaf-1* , 2000, The Journal of Biological Chemistry.

[33]  B. Stockwell.  Chemical genetics: ligand-based discovery of gene function , 2000, Nature Reviews Genetics.

[34]  J. Tschopp,et al.  The Long Form of FLIP Is an Activator of Caspase-8 at the Fas Death-inducing Signaling Complex* , 2002, The Journal of Biological Chemistry.

[35]  Brent R. Stockwell,et al.  An Induced Proximity Model for Caspase-8 Activation* , 1998, The Journal of Biological Chemistry.

[36]  Matthias Mann,et al.  FLICE, A Novel FADD-Homologous ICE/CED-3–like Protease, Is Recruited to the CD95 (Fas/APO-1) Death-Inducing Signaling Complex , 1996, Cell.

[37]  M. Peter,et al.  The CD95(APO-1/Fas) DISC and beyond , 2003, Cell Death and Differentiation.

[38]  T. Graybill,et al.  Preparation and evaluation of peptidic aspartyl hemiacetals as reversible inhibitors of interleukin-1 beta converting enzyme (ICE). , 2009, International journal of peptide and protein research.

[39]  D. Nicholson,et al.  Caspase structure, proteolytic substrates, and function during apoptotic cell death , 1999, Cell Death and Differentiation.

[40]  M. Grütter,et al.  Structure of Recombinant Human CPP32 in Complex with the Tetrapeptide Acetyl-Asp-Val-Ala-Asp Fluoromethyl Ketone* , 1997, The Journal of Biological Chemistry.

[41]  J. Mankovich,et al.  Crystal structure of the cysteine protease interleukin-1β-converting enzyme: A (p20/p10)2 homodimer , 1994, Cell.

[42]  M. Grütter,et al.  The three-dimensional structure of caspase-8: an initiator enzyme in apoptosis. , 1999, Structure.

[43]  P. Krammer,et al.  c-FLIPR, a New Regulator of Death Receptor-induced Apoptosis* , 2005, Journal of Biological Chemistry.

[44]  Emad S. Alnemri,et al.  correction: A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis , 2001, Nature.

[45]  P. Schultz,et al.  Development and characterization of nonpeptidic small molecule inhibitors of the XIAP/caspase-3 interaction. , 2003, Chemistry & biology.

[46]  James A. Wells,et al.  Direct activation of the apoptosis machinery as a mechanism to target cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[47]  A. Yang,et al.  Specific tumoricidal activity of a secreted proapoptotic protein consisting of HER2 antibody and constitutively active caspase-3. , 2003, Cancer research.

[48]  M. Peter,et al.  Interdimer processing mechanism of procaspase‐8 activation , 2003, The EMBO journal.

[49]  Rui Zhang,et al.  A Caspase-6 and Anti-Human Epidermal Growth Factor Receptor-2 (HER2) Antibody Chimeric Molecule Suppresses the Growth of HER2-Overexpressing Tumors1 , 2004, The Journal of Immunology.

[50]  G. Salvesen,et al.  The protein structures that shape caspase activity, specificity, activation and inhibition. , 2004, The Biochemical journal.

[51]  S. Korsmeyer,et al.  Pro-apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c , 2000, Cell Death and Differentiation.

[52]  Yigong Shi,et al.  Mechanisms of caspase activation and inhibition during apoptosis. , 2002, Molecular cell.

[53]  R. Huber,et al.  Crystal structure of gingipain R: an Arg‐specific bacterial cysteine proteinase with a caspase‐like fold , 1999, The EMBO journal.

[54]  K. O. Elliston,et al.  A novel heterodimeric cysteine protease is required for interleukin-1βprocessing in monocytes , 1992, Nature.

[55]  Sten Orrenius,et al.  Caspase-2 Acts Upstream of Mitochondria to Promote Cytochromec Release during Etoposide-induced Apoptosis* , 2002, The Journal of Biological Chemistry.

[56]  Xiaodong Wang,et al.  Smac, a Mitochondrial Protein that Promotes Cytochrome c–Dependent Caspase Activation by Eliminating IAP Inhibition , 2000, Cell.

[57]  N. Thornberry,et al.  The three-dimensional structure of apopain/CPP32, a key mediator of apoptosis , 1996, Nature Structural Biology.

[58]  H. Nakayama,et al.  A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. , 2001, Molecular cell.

[59]  Emad S. Alnemri,et al.  A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis , 2001, Nature.

[60]  J. Tschopp,et al.  Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors , 1997, Nature.

[61]  S. Srinivasula,et al.  Structural Basis of Caspase-7 Inhibition by XIAP , 2001, Cell.

[62]  M. Peter,et al.  FLICE Is Predominantly Expressed as Two Functionally Active Isoforms, Caspase-8/a and Caspase-8/b* , 1997, The Journal of Biological Chemistry.

[63]  Xuejun Jiang,et al.  Three-dimensional structure of the apoptosome: implications for assembly, procaspase-9 binding, and activation. , 2002, Molecular cell.

[64]  M. Peter,et al.  Isolation and analysis of components of CD95 (APO-1/Fas) death-inducing signaling complex. , 1999, Methods.

[65]  Christophe Briand,et al.  Crystal Structure of Caspase-2, Apical Initiator of the Intrinsic Apoptotic Pathway* , 2003, Journal of Biological Chemistry.

[66]  P. Krammer,et al.  CD95's deadly mission in the immune system , 2000, Nature.

[67]  Ximena Opitz-Araya,et al.  Requirement for Caspase-2 in Stress-Induced Apoptosis Before Mitochondrial Permeabilization , 2002, Science.

[68]  K. Wilson,et al.  The structures of caspases-1, -3, -7 and -8 reveal the basis for substrate and inhibitor selectivity. , 2000, Chemistry & biology.

[69]  Khashayar Karimian,et al.  Thiol-dependent enzymes and their inhibitors: a review. , 2002, Current medicinal chemistry.

[70]  Clemencia Pinilla,et al.  Small-molecule antagonists of apoptosis suppressor XIAP exhibit broad antitumor activity. , 2004, Cancer cell.

[71]  E. Estey,et al.  Effect of interleukin-1 beta converting enzyme inhibitor on acute myelogenous leukemia progenitor proliferation. , 1995, Blood.

[72]  P. Krammer,et al.  Cellular FLICE-inhibitory Protein Splice Variants Inhibit Different Steps of Caspase-8 Activation at the CD95 Death-inducing Signaling Complex* , 2001, The Journal of Biological Chemistry.

[73]  M. Hengartner.  Programmed cell death in the nematode C. elegans. , 1999, Recent progress in hormone research.

[74]  R. Liddington,et al.  Crystal structure of the apoptotic suppressor CrmA in its cleaved form. , 2000, Structure.

[75]  G M Cohen,et al.  Caspases: the executioners of apoptosis. , 1997, The Biochemical journal.

[76]  M. Peter,et al.  Cytotoxicity‐dependent APO‐1 (Fas/CD95)‐associated proteins form a death‐inducing signaling complex (DISC) with the receptor. , 1995, The EMBO journal.

[77]  David G. Myszka,et al.  Covalent inhibition revealed by the crystal structure of the caspase-8/p35 complex , 2001, Nature.

[78]  Junying Yuan,et al.  Human ICE/CED-3 Protease Nomenclature , 1996, Cell.

[79]  F. Martinon,et al.  The pyrin domain: a possible member of the death domain-fold family implicated in apoptosis and inflammation , 2001, Current Biology.

[80]  R. Siegel,et al.  Membrane Oligomerization and Cleavage Activates the Caspase-8 (FLICE/MACHα1) Death Signal* , 1998, The Journal of Biological Chemistry.

[81]  J. Blenis,et al.  Death Receptor Recruitment of Endogenous Caspase-10 and Apoptosis Initiation in the Absence of Caspase-8* , 2001, The Journal of Biological Chemistry.

[82]  Stephen W. Fesik,et al.  NMR structure and mutagenesis of the FADD (Mort1) death-effector domain , 1998, Nature.

[83]  Xiaolu Yang,et al.  c‐FLIPL is a dual function regulator for caspase‐8 activation and CD95‐mediated apoptosis , 2002, The EMBO journal.

[84]  N. Thornberry,et al.  A Combinatorial Approach Defines Specificities of Members of the Caspase Family and Granzyme B , 1997, The Journal of Biological Chemistry.

[85]  D. Scudiero,et al.  A high-throughput screen for identification of molecular mimics of Smac/DIABLO utilizing a fluorescence polarization assay. , 2003, Analytical biochemistry.

[86]  R. Liddington,et al.  Structural Basis for the Inhibition of Caspase-3 by XIAP , 2001, Cell.

[87]  E. Clementi,et al.  Inhibition of Caspase-1-Like Activity by Ac-Tyr-Val-Ala-Asp-Chloromethyl Ketone Induces Long-Lasting Neuroprotection in Cerebral Ischemia through Apoptosis Reduction and Decrease of Proinflammatory Cytokines , 2000, The Journal of Neuroscience.

[88]  A Krueger,et al.  The active caspase-8 heterotetramer is formed at the CD95 DISC , 2003, Cell Death and Differentiation.